Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma

Glioblastoma (GBM) is considered one of the most malignant, genetically heterogeneous, and therapy-resistant solid tumor. Therapeutic options are limited in GBM and involve surgical resection followed by chemotherapy and/or radiotherapy. Adjuvant therapies, including antiangiogenic treatments (AATs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Arbab, Ali S., Rashid, Mohammad H., Angara, Kartik, Borin, Thaiz F., Lin, Ping-Chang, Jain, Meenu, Achyut, Bhagelu R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751333/
https://www.ncbi.nlm.nih.gov/pubmed/29258180
http://dx.doi.org/10.3390/ijms18122732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751333/
https://www.ncbi.nlm.nih.gov/pubmed/29258180
http://dx.doi.org/10.3390/ijms18122732

Ejemplares similares